人胚胎干细胞建系及向神经细胞定向分化的研究

研究和利用人胚胎干细胞(hES)细胞已成为生命科学领域的核心问题之一。当前hES 细胞研究主要集中在hES 的建系和维持其不分化状态；提高hES 细胞定向分化为特定 细胞的比例；ES 细胞自我更新和分化的机制等方面。本论文一方面概述了hES 细胞相 关领域的研究进展；另一方面建立了不同培养体系条件下3 株hES 细胞，并在此基础 上利用G5 和肝生长因子（HGF）诱导hES 细胞定向分化成高纯度的NPs。主要结论如 下：1) 建立人卵体外受精和胚胎培养体系。获得了15 个囊胚，采用了免疫外科法分离 内细胞团，运用含血清以及不含血清的培养体系，在ICR 小鼠胚胎成纤维饲养层上分 别建立了YKh-1、YKh-2 和YKh-3 3 株人胚胎干细胞系，生长良好，核型正常。ES 细 胞表达碱性磷酸酶活性、SSEA-3、SSEA-4、TRA-1-60、TRA-1-81 和Oct-4，但不表达 SSEA-1； ES 细胞在体外能够分化为属于外胚层、中胚层和内胚层的各种分化细胞， 在SCID 小鼠体内能形成畸胎瘤，畸胎瘤包括了所有三个胚层来源的细胞类型。证实了 ES 细胞系的多向分化潜能。2) 对比含血清以及无血清的培养体系的hES 细胞系的特征， 观察了其集落形态、生长速度、分化能力。结果表明，在含血清培养体系的Yhk-2，其 集落形态较致密，含2-3 个核的细胞较多，细胞倍增时间为43.9±5.7h；而在无血清培 养体系的Yhk-3，其集落形态较铺展，细胞较小而圆，倍增时间为34.8±3.8h。细胞免疫 染色和PCR 结果表明，二者在体外都能分化为三个胚层来源的多种细胞，但比例有所 差异。提示二者在向三个胚层来源的细胞的分化能力上有所不同。 3) 以所建立的hES 细胞系为模型，采用HGF 和G5 作为诱导因子添加到神经诱导培养基中，诱导hES 细 胞分化成高纯度的NPs。单独的HGF 或G5 仅能诱导ES 细胞分化成70.9± 5.0%和 72.9±7.2%NPs，而联用HGF 和G5 使NPs 的比率达到91.2±11.2%，进一步纯化后获得 98±3.2%的NPs。获得的NPs 能分化成三个谱系神经细胞，亚克隆实验也进一步证明采 用HGF+G5 获得的单个NPs 具有神经干细胞的特性，也能在体外分化成三个谱系的神 经细胞。用SHH 处理NPs，获得的分化细胞表达不同脑区标志，表明所得到NPs 具有 对脑区信号发生反应，进一步分化为不同脑区神经元细胞的能力。 本实验建立了具有自主知识产权的中国人源胚胎干细胞系，建立了ES 细胞的含血 清以及无血清的培养体系和向神经前体细胞定向分化系统，得到高比例的神经前体细 胞，为进一步研究利用人胚胎干细胞打下良好的基础。

人胚胎干细胞定向分化为神经前体细胞

人胚胎干细胞(human embryonic stem cells, hES细胞)来源于植入前胚胎的内细胞团，具有自我更新能力和发育全能性，能够在体内外分化为代表三个胚层的细胞类型。hES细胞来源的神经前体细胞（neural progenitor）对于研究胚胎早期的神经发育以及药物筛选和神经系统疾病的细胞替代性治疗具有重要意义。然而，许多因素影响了ES细胞的临床应用，如供体细胞不足、纯度低、异源物质污染等。 本研究采用同源饲养层培养的hES细胞在单层培养条件下高效地分化得到了神经前体细胞。主要结论如下：1）hES细胞在同源饲养层HAFi上培养八个月后仍保持ES细胞的各项表型特征和抗原特性。表明HAFi能够支持hES细胞的长期培养，从培养条件上避免了异源物质污染的可能性。2）单层贴壁分化的方法培养成分简单，不含血清和条件培养基，不需繁琐的筛选步骤就可以得到高比例的神经前体细胞（97.5%±0.83%）（P＜0.05）。此外，成分确定的培养基是研究神经分化的分子机制的良好模型。3）hES细胞来源的神经前体细胞具有分化为神经元，星形胶质和少突胶质细胞的能力，并能够模拟体内神经发育的过程和分子表达模式。长期的传代培养中发现，随着培养时间的延长，nestin阳性的神经前体细胞比例下降，同时发育能力也发生了变化。在传代培养的早期，神经前体细胞发育为神经元的比例很高，几乎没有胶质细胞分化出来。随培养时间的延长，胶质细胞的比例逐渐上升。进一步研究发现具有bHLH (basic helix-loop-helix) 结构域的转录因子neurogenein2(Ngn2) 和olig2可能在这一变化中发挥了重要的作用。

猕猴胚胎干细胞培养以及定向分化成神经细胞的研究

灵长类胚胎干细胞（Es）的研究不仅对理解生殖发育生物学的基础理论、而且对实现细胞替代治疗具有重要意义。当前灵长类ES细胞还有很多问题需要解决，如ES细胞培养体系的改进、ES细胞定向分化成高纯度特定组织细胞的可能性、有效性以及分化机制等问题。本文一方面概述了灵长类ES细胞相关领域的研究进展；另一方面，以称猴胚胎干细胞（rEs）为材料，在改善rES细胞的培养体系、提高其定向分化成神经前体细胞（NPs）和少突细胞的比率进行了研究。实验采用同源称猴细胞系作为饲养层培养rES细胞，并在此基础上利用肝生长因子（HGF）和GS诱导rES细胞定向分化成高纯度的NPs和少突细胞，并评价了NPs是否具有移植功能。主要结论如下：1）四种称猴细胞系（MOF、MESF、MFG和CMESF）可作为饲养层支持rES细胞的生长，保持ES自我更新的能力和分化的多能性。而且这几种称猴饲养层支持ES细胞生长的能力存在明显的差异，进一步的研究表明这些差异主要是由于基因表达种类以及表达量上的差异而导致的。2）采用HGF和GS作为诱导因子添加到NDCM液中，诱导rES细胞分化成可移植的NPs。实验结果如下：单独的HGF或GS仅能诱导ES细胞分化成65±8.3％和69±14％NPs，而HGF和GS的联合使用NPs的比率达到88.3±8.1％，进一步纯化后获得98±1.2％的NPs。获得的NPs能在体内、外分化成三个谱系神经细胞，并能整合到大鼠脑部，发生迁移和分化。25％的NPs细胞8周后仍保持存活状态，其中65-80％的细胞发生了不同程度的迁移，而且细胞在脑部的分化种类以及数目与细胞在体内所处的微环境具有重要的关系。亚克隆实验也进一步证明采用HGF＋GS获得的部分单个NPs具有神经干细胞的特性，也能在体内、外分化成三个谱系的神经细胞，而另外的却只能分化成其中的一、两种谱系的细胞。3）利用五步法，ES细胞能分化成75±6.8％的少突祖细胞和81土8．6％的成熟少突细胞。HGF通过抑制NPs的凋亡和缩短NPs的复制周期，共同促进NPs的增殖。HGF也能诱导HGF+G5获得的NPs分化成少突祖细胞和成熟少突细胞，并且促进少突细胞成熟。而且HGF促进NPs分化成少突细胞的能力受到GS的调控，单独HGF作用将导致ES细胞分化成神经元。本实验的结果为促进rES细胞相关领域的研究，以及ES细胞在神经系统疾病临床应用上提供信息，也为研究NPs和少突细胞的发育提供典型的细胞模型。

猕猴胚胎干细胞的神经谱系分化及胶质祖细胞迁移机理研究

由于伦理和材料来源的限制，目前对灵长类早期神经发育缺乏深入地了解。与啮齿类动物相比，猕猴在遗传和生理上与人类更接近，因此猕猴胚胎干细胞(rESCs)研究具有重要的研究价值，不仅能为研究发育生物学基础理论提供良好的模型，而且可为细胞替代性治疗提供大量的供体细胞。本文以rESCs为主要研究对象，在rESCs定向分化为神经细胞的基础上着重研究神经谱系分化及调控胶质祖细胞迁移的机理。主要结论如下：1) rESCs来源的神经上皮干/前体细胞(NEPs)主要变为辐射状胶质细胞(RG)后再通过中间类型的祖细胞——神经元祖细胞(NPs)和胶质祖细胞(GPs)——分别分化为神经元和胶质细胞。同时，NEPs/RG细胞群具有早期神经管背-腹和前-后轴空间特性。NEPs/RG的维持受Notch和FGFR信号作用。此外，实验中还纯化和鉴定了猕猴胶质限定性前体细胞(GRPs)。结果表明，rESCs的神经谱系分化能够模拟体内发育过程，并与啮齿类动物早期神经谱系变化过程相似。2) 气体信号分子NO(由10μM—250μM SNP供体释放)促进rESCs来源的A2B5+/Nestin/PSA-NCAM胶质祖细胞迁移。进一步研究发现Netrin-DCC信号通路介导了NO启动的细胞迁移过程。同时，Ca2也参与调控胶质祖细胞的迁移。此外，细胞外基质和整合素α6亦可能与Netrin-DCC相互作用调控细胞迁移。结果显示，NO通过激活一个复杂的信号网络系统调控胶质祖细胞迁移。本实验的研究结果有助于揭示灵长类中枢神经系统发育的机理，同时也能为治疗神经系统退行性疾病提供阶段特异性的供体细胞。

Phenoloxidase, a marker enzyme for differentiation of the neural ectoderm and the epidermal ectoderm during embryonic development of amphioxus Branchiostoma belcheri tsingtaunese

The development of phenoloxidase during amphioxus embryogenesis was spectrophotometrically and histochemically studied for the first time in the present study. It was found that (1) PO activity initially appeared in the general ectoderm including the neural ectoderm and the epidermal ectoderm at the early neurala stage but not in the mesoderm or the endoderm, and (2) PO activity disappeared in the neural plate cells but remained unchanged in the epidermal cells when the neural plate was morphologically quite distinct from the rest of the ectoderm. It is apparent that PO could serve as a marker enzyme for differentiation of the neural ectoderm from the epidermal ectoderm during embryonic development of amphioxus. (C) 2000 Elsevier Science ireland Ltd. All rights reserved.

Mesenchymal stem cell therapy for the treatment of myocardial infarction

Mesenchymal stem cells (MSCs) are currently under investigation as repair agents in the preservation of cardiac function following myocardial infarction (MI). However concerns have emerged regarding the safety of acute intracoronary (IC) MSC delivery specifically related to mortality, micro-infarction and microvascular flow restriction post cell therapy in animal models. This thesis aimed to firstly identify an optimal dose of MSC that could be tolerated when delivered via the coronary artery in a porcine model of acute MI (AMI). Initial dosing studies identified 25x106 MSC to be a safe MSC cell dose, however, angiographic observations from these studies recognised that on delivery of MSC there was a significant adverse decrease in distal blood flow within the artery. This observation along with additional supportive data in the literature (published during the course of this thesis) suggested MSC may be contributing to such adverse events through the propagation of thrombosis. Therefore further studies aimed to investigate the innate prothrombotic activity of MSC. Expression of the initiator of the coagulation cascade initiator tissue factor (TF) on MSC was detected in high levels on the surface of these cells. MSC-derived TF antigen was catalytically active, capable of supporting thrombin generation in vitro and enhancing platelet-driven thrombus deposition on collagen under flow. Infusion of MSC via IC route was associated with a decreased coronary flow reserve when delivered but not when coadministered with an antithrombin agent heparin. Heparin also reduced MSC-associated in situ thrombosis incorporating platelets and VWF in the microvasculature. Heparin-assisted MSC delivery reduced acute apoptosis and significantly improved infarct size, left ventricular ejection fraction, LV volumes, wall motion and scar formation at 6 weeks post AMI. In addition, this thesis investigated the paracrine factors secreted by MSC, in particular focusing on the effect on cardiac repair of a novel MSC-paracrine factor SPARCL1. In summary this work provides new insight into the mechanism by which MSC may be deleterious when delivered by an IC route and a means of abrogating this effect. Moreover we present new data on the MSC secretome with elucidation of the challenges encountered using a single paracrine factor cardiac repair strategy.

Deformation of stem cell nuclei by nanotopographical cues.

Cells sense cues in their surrounding microenvironment. These cues are converted into intracellular signals and transduced to the nucleus in order for the cell to respond and adapt its function. Within the nucleus, structural changes occur that ultimately lead to changes in the gene expression. In this study, we explore the structural changes of the nucleus of human mesenchymal stem cells as an effect of topographical cues. We use a controlled nanotopography to drive shape changes to the cell nucleus, and measure the changes with both fluorescence microscopy and a novel light scattering technique. The nucleus changes shape dramatically in response to the nanotopography, and in a manner dependent on the mechanical properties of the substrate. The kinetics of the nuclear deformation follows an unexpected trajectory. As opposed to a gradual shape change in response to the topography, once the cytoskeleton attains an aligned and elongation morphology on the time scale of several hours, the nucleus changes shape rapidly and intensely.

Targeting A20 decreases glioma stem cell survival and tumor growth.

Glioblastomas are deadly cancers that display a functional cellular hierarchy maintained by self-renewing glioblastoma stem cells (GSCs). GSCs are regulated by molecular pathways distinct from the bulk tumor that may be useful therapeutic targets. We determined that A20 (TNFAIP3), a regulator of cell survival and the NF-kappaB pathway, is overexpressed in GSCs relative to non-stem glioblastoma cells at both the mRNA and protein levels. To determine the functional significance of A20 in GSCs, we targeted A20 expression with lentiviral-mediated delivery of short hairpin RNA (shRNA). Inhibiting A20 expression decreased GSC growth and survival through mechanisms associated with decreased cell-cycle progression and decreased phosphorylation of p65/RelA. Elevated levels of A20 in GSCs contributed to apoptotic resistance: GSCs were less susceptible to TNFalpha-induced cell death than matched non-stem glioma cells, but A20 knockdown sensitized GSCs to TNFalpha-mediated apoptosis. The decreased survival of GSCs upon A20 knockdown contributed to the reduced ability of these cells to self-renew in primary and secondary neurosphere formation assays. The tumorigenic potential of GSCs was decreased with A20 targeting, resulting in increased survival of mice bearing human glioma xenografts. In silico analysis of a glioma patient genomic database indicates that A20 overexpression and amplification is inversely correlated with survival. Together these data indicate that A20 contributes to glioma maintenance through effects on the glioma stem cell subpopulation. Although inactivating mutations in A20 in lymphoma suggest A20 can act as a tumor suppressor, similar point mutations have not been identified through glioma genomic sequencing: in fact, our data suggest A20 may function as a tumor enhancer in glioma through promotion of GSC survival. A20 anticancer therapies should therefore be viewed with caution as effects will likely differ depending on the tumor type.

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells.

Increased understanding of the precise molecular mechanisms involved in cell survival and cell death signaling pathways offers the promise of harnessing these molecules to eliminate cancer cells without damaging normal cells. Tyrosine kinase oncoproteins promote the genesis of leukemias through both increased cell proliferation and inhibition of apoptotic cell death. Although tyrosine kinase inhibitors, such as the BCR-ABL inhibitor imatinib, have demonstrated remarkable efficacy in the clinic, drug-resistant leukemias emerge in some patients because of either the acquisition of point mutations or amplification of the tyrosine kinase, resulting in a poor long-term prognosis. Here, we exploit the molecular mechanisms of caspase activation and tyrosine kinase/adaptor protein signaling to forge a unique approach for selectively killing leukemic cells through the forcible induction of apoptosis. We have engineered caspase variants that can directly be activated in response to BCR-ABL. Because we harness, rather than inhibit, the activity of leukemogenic kinases to kill transformed cells, this approach selectively eliminates leukemic cells regardless of drug-resistant mutations.

Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues.

The mammalian heart has little capacity to regenerate, and following injury the myocardium is replaced by non-contractile scar tissue. Consequently, increased wall stress and workload on the remaining myocardium leads to chamber dilation, dysfunction, and heart failure. Cell-based therapy with an autologous, epigenetically reprogrammed, and cardiac-committed progenitor cell source could potentially reverse this process by replacing the damaged myocardium with functional tissue. However, it is unclear whether cardiac progenitor cell-derived cardiomyocytes are capable of attaining levels of structural and functional maturity comparable to that of terminally-fated cardiomyocytes. Here, we first describe the derivation of mouse induced pluripotent stem (iPS) cells, which once differentiated allow for the enrichment of Nkx2-5(+) cardiac progenitors, and the cardiomyocyte-specific expression of the red fluorescent protein. We show that the cardiac progenitors are multipotent and capable of differentiating into endothelial cells, smooth muscle cells and cardiomyocytes. Moreover, cardiac progenitor selection corresponds to cKit(+) cell enrichment, while cardiomyocyte cell-lineage commitment is concomitant with dual expression of either cKit/Flk1 or cKit/Sca-1. We proceed to show that the cardiac progenitor-derived cardiomyocytes are capable of forming electrically and mechanically coupled large-scale 2D cell cultures with mature electrophysiological properties. Finally, we examine the cell progenitors' ability to form electromechanically coherent macroscopic tissues, using a physiologically relevant 3D culture model and demonstrate that following long-term culture the cardiomyocytes align, and form robust electromechanical connections throughout the volume of the biosynthetic tissue construct. We conclude that the iPS cell-derived cardiac progenitors are a robust cell source for tissue engineering applications and a 3D culture platform for pharmacological screening and drug development studies.

Calcium dependent CAMTA1 in adult stem cell commitment to a myocardial lineage.

The phenotype of somatic cells has recently been found to be reversible. Direct reprogramming of one cell type into another has been achieved with transduction and over expression of exogenous defined transcription factors emphasizing their role in specifying cell fate. To discover early and novel endogenous transcription factors that may have a role in adult-derived stem cell acquisition of a cardiomyocyte phenotype, mesenchymal stem cells from human and mouse bone marrow and rat liver were co-cultured with neonatal cardiomyocytes as an in vitro cardiogenic microenvironment. Cell-cell communications develop between the two cell types as early as 24 hrs in co-culture and are required for elaboration of a myocardial phenotype in the stem cells 8-16 days later. These intercellular communications are associated with novel Ca(2+) oscillations in the stem cells that are synchronous with the Ca(2+) transients in adjacent cardiomyocytes and are detected in the stem cells as early as 24-48 hrs in co-culture. Early and significant up-regulation of Ca(2+)-dependent effectors, CAMTA1 and RCAN1 ensues before a myocardial program is activated. CAMTA1 loss-of-function minimizes the activation of the cardiac gene program in the stem cells. While the expression of RCAN1 suggests involvement of the well-characterized calcineurin-NFAT pathway as a response to a Ca(2+) signal, the CAMTA1 up-regulated expression as a response to such a signal in the stem cells was unknown. Cell-cell communications between the stem cells and adjacent cardiomyocytes induce Ca(2+) signals that activate a myocardial gene program in the stem cells via a novel and early Ca(2+)-dependent intermediate, up-regulation of CAMTA1.

Patient-derived endothelial progenitor cells improve vascular graft patency in a rodent model.

Late outgrowth endothelial progenitor cells (EPCs) derived from the peripheral blood of patients with significant coronary artery disease were sodded into the lumens of small diameter expanded polytetrafluoroethylene (ePTFE) vascular grafts. Grafts (1mm inner diameter) were denucleated and sodded either with native EPCs or with EPCs transfected with an adenoviral vector containing the gene for human thrombomodulin (EPC+AdTM). EPC+AdTM was shown to increase the in vitro rate of graft activated protein C (APC) production 4-fold over grafts sodded with untransfected EPCs (p<0.05). Unsodded control and EPC-sodded and EPC+AdTM-sodded grafts were implanted bilaterally into the femoral arteries of athymic rats for 7 or 28 days. Unsodded control grafts, both with and without denucleation treatment, each exhibited 7 day patency rates of 25%. Unsodded grafts showed extensive thrombosis and were not tested for patency over 28 days. In contrast, grafts sodded with untransfected EPCs or EPC+AdTM both had 7 day patency rates of 88-89% and 28 day patency rates of 75-88%. Intimal hyperplasia was observed near both the proximal and distal anastomoses in all sodded graft conditions but did not appear to be the primary occlusive failure event. This in vivo study suggests autologous EPCs derived from the peripheral blood of patients with coronary artery disease may improve the performance of synthetic vascular grafts, although no differences were observed between untransfected EPCs and TM transfected EPCs.

A Tissue-Engineered Microvascular System to Evaluate Vascular Progenitor Cells for Angiogenic Therapies

The ability of tissue engineered constructs to replace diseased or damaged organs is limited without the incorporation of a functional vascular system. To design microvasculature that recapitulates the vascular niche functions for each tissue in the body, we investigated the following hypotheses: (1) cocultures of human umbilical cord blood-derived endothelial progenitor cells (hCB-EPCs) with mural cells can produce the microenvironmental cues necessary to support physiological microvessel formation in vitro; (2) poly(ethylene glycol) (PEG) hydrogel systems can support 3D microvessel formation by hCB-EPCs in coculture with mural cells; (3) mesenchymal cells, derived from either umbilical cord blood (MPCs) or bone marrow (MSCs), can serve as mural cells upon coculture with hCB-EPCs. Coculture ratios between 0.2 (16,000 cells/cm2) and 0.6 (48,000 cells/cm2) of hCB-EPCs plated upon 3.3 µg/ml of fibronectin-coated tissue culture plastic with (80,000 cells/cm2) of human aortic smooth muscle cells (SMCs), results in robust microvessel structures observable for several weeks in vitro. Endothelial basal media (EBM-2, Lonza) with 9% v/v fetal bovine serum (FBS) could support viability of both hCB-EPCs and SMCs. Coculture spatial arrangement of hCB-EPCs and SMCs significantly affected network formation with mixed systems showing greater connectivity and increased solution levels of angiogenic cytokines than lamellar systems. We extended this model into a 3D system by encapsulation of a 1 to 1 ratio of hCB-EPC and SMCs (30,000 cells/µl) within hydrogels of PEG-conjugated RGDS adhesive peptide (3.5 mM) and PEG-conjugated protease sensitive peptide (6 mM). Robust hCB-EPC microvessels formed within the gel with invasion up to 150 µm depths and parameters of total tubule length (12 mm/mm2), branch points (127/mm2), and average tubule thickness (27 µm). 3D hCB-EPC microvessels showed quiescence of hCB-EPCs (<1% proliferating cells), lumen formation, expression of EC proteins connexin 32 and VE-cadherin, eNOS, basement membrane formation by collagen IV and laminin, and perivascular investment of PDGFR-β+/α-SMA+ cells. MPCs present in <15% of isolations displayed >98% expression for mural markers PDGFR-β, α-SMA, NG2 and supported hCB-EPC by day 14 of coculture with total tubule lengths near 12 mm/mm2. hCB-EPCs cocultured with MSCs underwent cell loss by day 10 with a 4-fold reduction in CD31/PECAM+ cells, in comparison to controls of hCB-EPCs in SMC coculture. Changing the coculture media to endothelial growth media (EBM-2 + 2% v/v FBS + EGM-2 supplement containing VEGF, FGF-2, EGF, hydrocortisone, IGF-1, ascorbic acid, and heparin), promoted stable hCB-EPC network formation in MSC cocultures over 2 weeks in vitro, with total segment length per image area of 9 mm/mm2. Taken together, these findings demonstrate a tissue engineered system that can be utilized to evaluate vascular progenitor cells for angiogenic therapies.

A miR-34a-Numb Feedforward Loop Triggered by Inflammation Regulates Asymmetric Stem Cell Division in Intestine and Colon Cancer.

Emerging evidence suggests that microRNAs can initiate asymmetric division, but whether microRNA and protein cell fate determinants coordinate with each other remains unclear. Here, we show that miR-34a directly suppresses Numb in early-stage colon cancer stem cells (CCSCs), forming an incoherent feedforward loop (IFFL) targeting Notch to separate stem and non-stem cell fates robustly. Perturbation of the IFFL leads to a new intermediate cell population with plastic and ambiguous identity. Lgr5+ mouse intestinal/colon stem cells (ISCs) predominantly undergo symmetric division but turn on asymmetric division to curb the number of ISCs when proinflammatory response causes excessive proliferation. Deletion of miR-34a inhibits asymmetric division and exacerbates Lgr5+ ISC proliferation under such stress. Collectively, our data indicate that microRNA and protein cell fate determinants coordinate to enhance robustness of cell fate decision, and they provide a safeguard mechanism against stem cell proliferation induced by inflammation or oncogenic mutation.

Systemic recruitment of osteoblastic cells in fracture healing

We hypothesise that following a bone fracture there is systemic recruitment of bone forming cells to a fracture site. A rabbit ulnar osteotomy model was adapted to trace the movement of osteogenic cells. Bone marrow mesenchymal stem cells from 41 NZW rabbits were isolated, culture-expanded and fluorescently labelled. The labelled cells were either re-implanted into the fracture gap (Group A); into a vein (Group B); or into a remote tibial bone marrow cavity 48 h after the osteotomy (Group C) or 4 weeks before the osteotomy was established (Group D), and a control group (Group E) had no labelled cells given. To quantify passive leakage of cells to an injury site, inert beads were also co-delivered in Group B. Samples of the fracture callus tissue and various organs were harvested at discrete sacrifice time-points to trace and quantify the labelled cells. At 3 weeks following osteotomy, the number of labelled cells identified in the callus of Group C, was significantly greater than following IV delivery, Group B, and there was no difference in the number of labelled cells in the callus tissues, between Groups C and A, indicating the labelled bone marrow cells were capable of migrating to the fracture sites from the remote bone marrow cavity. Significantly fewer inert beads than labelled cells were identified in Group B callus, suggesting some of the bone-forming cells were actively recruited and selectively chosen to the fracture site, rather than passively leaked into the circulation and to bone injury site. This investigation supports the hypothesis that some osteoblasts involved in fracture healing were systemically mobilised and recruited to the fracture from remote bone marrow sites. © 2005 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.